Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Sugammadex

Poitiers University Hospital

Status: Completed

Conditions: Postoperative Residual Curarization

Treatments: Device: TOF SCAN; Device: ITF

Study type: Interventional

Funder types: Other

Identifiers

NCT05003024

DECURATOF

Details and patient eligibility

About

Despite neuromuscular transmission monitoring and pharmacological reversal allowing a train of four ratio recovery higher than 0.9, patients receiving neuromuscular blocking agent during general anesthesia have a high risk of postoperative pulmonary complications. While this train of four ratio thershold is considered as the gold standard to confirm the lack of residual paralysis, tetanus 100 Hz stimulation showed a marked fade. This result has been observed in absence of reversal agent administration.

Therefore, the present study has been designed to compare the recovery of train of four stimulation, tetanus 50 Hz and tetanus 100 Hz stimulation in patient receiving rocuronium during general anesthesia and reversed by a specific reversal agent (sugammadex). The sugammedex will be injected once two muscular contractions of the adductor pollicis muscle will be observed after a train of four stimulation, at a dose (2mg/kg) in accordance with the clinical practice worldwide admitted.

Two questions have to be investigated. First, is this dose of sugammadex sufficient to allow a complete recovery of tetanus stimulations? Second, due to the pharmacological properties of sugammadex, does a recurarisation phenomenon occur following repeated tetanus stimulations? The attented results of this study will be to propose a new thinking on what we really need to make relevant progress in the safety aspects of residual paralysis outcome.

Enrollment: 21 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA clinical status 1 to 3
• Informed consent obtained before anesthesia induction

Exclusion criteria

• ASA clinical status 4
• Emergency surgery; scheduled surgery in prone position,
• Hepatic or renal disease,
• BMI higher than 35,
• Allergy to rocuronium or sugammadex

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

21 participants in 2 patient groups

TOF scan train of four ratio monitoring

Active Comparator group

Description:

Recovery of train of four ratio after sugammadex administration

Treatment:

Device: TOF SCAN

ITF device tetanus stimulation monitoring

Experimental group

Description:

Recovery of tetanus 100 Hz ratio after sugamamdex administration

Treatment:

Device: ITF